Drug Trial Radar · NCT06335173
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
542
Actual
Start
Feb 29, 2024
Primary completion
Oct 29, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Acumen PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the efficacy of sabirnetug infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.
Conditions
- Alzheimer Disease
Interventions
sabirnetugDrug
Intravenous sabirnetug
PlaceboDrug
Intravenous Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Integrated Alzheimer's Disease Rating Scale (iADRS) ScoreTime frame: Baseline up to Week 80
Locations
68 sites in 5 countries. Site status is shown where the registry gives one.
The Neurology Center of Southern California - Carlsbad
Carlsbad, California
Neurology Center of North Orange County
Fullerton, California
Irvine Medical Research
Irvine, California
Healthy Brain Research
Long Beach, California
Syrentis Clinical Research
Santa Ana, California
CenExel - California Neuroscience Research Medical Group, Inc (CNR)
Sherman Oaks, California
Research Center for Clinical Studies, LLC
Norwalk, Connecticut
Re:Cognition Health - Fairfax
Washington D.C., District of Columbia
JEM Research Institute
Atlantis, Florida
Bradenton Research Center
Bradenton, Florida
Gil Fernandez-Yera, MD, PA
Coral Gables, Florida
Brain Matters Research
Delray Beach, Florida
Coral Clinical Research
Homestead, Florida
K2 Medical Research - Villages
Lady Lake, Florida
Finlay Medical Research
Miami, Florida
Aqualane Clinical Research
Naples, Florida
Ocala Health - Family Care Specialists - Ocala I
Ocala, Florida
Progressive Medical Research
Port Orange, Florida
Alzheimer's Research and Treatment Center - Stuart
Stuart, Florida
K2 Medical Research - Tampa
Tampa, Florida
Charter Research - Lady Lake
The Villages, Florida
Alzheimers Research and Treatment Center - Wellington
Wellington, Florida
Conquest Research
Winter Park, Florida
Charter Research - Winter Park
Winter Park, Florida
Columbus Memory Center
Columbus, Georgia
CenExel - iResearch Atlanta
Decatur, Georgia
Office of Jeffrey S. Ross, MD
Northbrook, Illinois
Boston Center for Memory
Newton, Massachusetts
Hattiesburg Clinic - Memory Center
Hattiesburg, Mississippi
ActivMed Practices and Research
Portsmouth, New Hampshire
The Cognitive and Research Center of New Jersey
Springfield, New Jersey
CenExel - Advanced Memory Research Institute of NJ
Toms River, New Jersey
Neurological Associates of Albany
Albany, New York
AMC Research
Matthews, North Carolina
Cleveland Clinic
Cleveland, Ohio
Summit Research Network
Portland, Oregon
Abington Neurological Associates
Abington, Pennsylvania
Keystone Clinical Research
Norristown, Pennsylvania
Rhode Island Mood and Memory
East Providence, Rhode Island
Neurology Clinic. P.C
Cordova, Tennessee
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.